甲状腺酸与cDMARDs结合在类风湿性关节炎中的有效性
1Children's Immunity Laboratory, Renhe Hospital Affiliated to Three Gorges University, Yichang City, China. cao1512023@163.com.
European review for medical and pharmacological sciences
|October 22, 2024
概括
将全转网红酸添加到传统治疗中,显著改善了风湿性关节炎 (RA) 儿童的治疗结果. 这种组合疗法为治疗这种慢性自身免疫性疾病提供了更高的疗效.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节疼痛,炎症和损伤.
- 目前的RA管理通常涉及多种治疗策略.
- 常规疾病修饰性抗性药物 (cDMARDs) 是 RA 治疗的基石.
研究的目的:
- 调查全跨视网酸作为儿科类类风湿性关节炎辅助疗法的潜力.
- 评估是否添加全转录氨酸增强了传统的RA治疗 (cDMARDs) 的疗效.
主要方法:
- 一项涉及90名RA儿童的研究,从2020年到2022年.
- 两个队列:一个接受cDMARDs (甲托雷克萨特,莱夫卢诺米德),另一个接受cDMARDs加全跨视网酸.
- 通过主观报告,临床检查和6个月和1年后的成像检查来评估有效性.
主要成果:
- 仅服用cDMARDs的组在6个月后显示57.8%的积极结果.
- 接受全转录氨酸和cDMARDs的组显示出更好的结果.
- 33.3%的患者出现显著改善,33.3%的患者出现中度改善.
结论:
- 当添加到cDMARDs时,全转录氨基酸显著提高了RA儿童的治疗疗效.
- 这种组合疗法在治疗儿科类风湿性关节炎方面是一个有希望的进步.
- 进一步的研究可能会探讨在RA治疗中全转网红酸的长期益处和最佳剂量.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:29Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
01:29Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117